|
Market Closed -
NYSE
16:00:02 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 75.33 USD | -1.13% |
|
-2.31% | +27.29% |
| 07-30 | Ingevity Corporation, Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Ingevity's Q2 Adjusted Earnings Increase, Net Sales Decline; 2026 Adjusted EPS Outlook Raised | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 89 | +16.81% | 3 | |||||||
| 7,839.41 | +22.3% | 17 | |||||||
| 52.6 | +2.58% | 21 | |||||||
| 1,780.62 | +4.65% | 21 | |||||||
| 1,967.5 | +13.47% | 12 | |||||||
| 1,158.33 | -7.07% | 12 | |||||||
| 56.93 | -6.89% | 14 | |||||||
| 77.41 | -4.2% | 16 | |||||||
| 2,933.27 | +13.87% | 30 | |||||||
| 203.11 | +9.11% | 9 | |||||||
| 8,311.11 | +4.9% | 9 | |||||||
| - | - | 39 | +4.28% | 1 | |||||
| 23.65 | +9.5% | 16 | |||||||
| 649 | +23.41% | 10 | |||||||
| 3,092.22 | +13% | 9 | |||||||
| 80.18 | +7.31% | 11 | |||||||
| 25.05 | -5.98% | 15 | |||||||
| 18.95 | +8.97% | 6 | |||||||
| Average | 1,577.63 | +7.22% | 13 | ||||||
| Weighted average by Cap. | 3,109.78 | +10.01% | 16 |
- Stock Market
- Stocks
- NGVT Stock
- Sector Ingevity Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















